Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Related Citations for PubMed (Select 24361370)

1.

Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.

Gantzsch SP, Kann B, Ofer-Glaessgen M, Loos P, Berchtold H, Balbach S, Eichinger T, Lehr CM, Schaefer UF, Windbergs M.

J Control Release. 2014 Feb 10;175:79-86. doi: 10.1016/j.jconrel.2013.12.009. Epub 2013 Dec 19.

PMID:
24361370
2.

Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.

Motz SA, Schaefer UF, Balbach S, Eichinger T, Lehr CM.

Eur J Pharm Biopharm. 2007 May;66(2):286-95. Epub 2006 Oct 28.

PMID:
17156983
3.
4.

Development of a biomimetic phospholipid vesicle-based permeation assay for the estimation of intestinal drug permeability.

Naderkhani E, Isaksson J, Ryzhakov A, Flaten GE.

J Pharm Sci. 2014 Jun;103(6):1882-90. doi: 10.1002/jps.23954. Epub 2014 Mar 24.

PMID:
24665049
6.

In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.

Kanzer J, Tho I, Flaten GE, Mägerlein M, Hölig P, Fricker G, Brandl M.

J Pharm Pharmacol. 2010 Nov;62(11):1591-8. doi: 10.1111/j.2042-7158.2010.01172.x.

PMID:
21039543
7.

New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier.

Engesland A, Skar M, Hansen T, Škalko-Basnet N, Flaten GE.

J Pharm Sci. 2013 May;102(5):1588-600. doi: 10.1002/jps.23509. Epub 2013 Mar 25.

PMID:
23529812
8.

Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system.

Ginski MJ, Polli JE.

Int J Pharm. 1999 Jan 15;177(1):117-25.

PMID:
10205608
9.

IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system.

Buch P, Langguth P, Kataoka M, Yamashita S.

J Pharm Sci. 2009 Jun;98(6):2001-9. doi: 10.1002/jps.21576.

PMID:
18855916
10.

Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay.

Naderkhani E, Erber A, Škalko-Basnet N, Flaten GE.

J Pharm Sci. 2014 Feb;103(2):661-8. doi: 10.1002/jps.23845. Epub 2014 Jan 6.

PMID:
24395733
11.
12.

Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.

Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.

Eur J Pharm Biopharm. 2008 Sep;70(1):289-301. doi: 10.1016/j.ejpb.2008.03.021. Epub 2008 Apr 22.

PMID:
18539015
13.

Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine.

Hiremath PS, Soppimath KS, Betageri GV.

Int J Pharm. 2009 Oct 1;380(1-2):96-104. doi: 10.1016/j.ijpharm.2009.07.008. Epub 2009 Jul 17.

PMID:
19616608
14.

The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations.

Sugawara M, Kadomura S, He X, Takekuma Y, Kohri N, Miyazaki K.

Eur J Pharm Sci. 2005 Sep;26(1):1-8.

PMID:
15961297
15.

Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.

Missaghi S, Young C, Fegely K, Rajabi-Siahboomi AR.

Drug Dev Ind Pharm. 2010 Feb;36(2):180-9. doi: 10.3109/03639040903468811.

PMID:
20070183
16.

In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants.

Fischer SM, Flaten GE, Hagesæther E, Fricker G, Brandl M.

J Pharm Pharmacol. 2011 Aug;63(8):1022-30. doi: 10.1111/j.2042-7158.2011.01301.x. Epub 2011 Jun 15.

PMID:
21718285
17.

Alternative oral exemestane formulation: improved dissolution and permeation.

Yavuz B, Bilensoy E, Vural I, Sumnu M.

Int J Pharm. 2010 Oct 15;398(1-2):137-45. doi: 10.1016/j.ijpharm.2010.07.046. Epub 2010 Aug 3.

PMID:
20678561
18.

Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers.

Beck RC, Pohlmann AR, Hoffmeister C, Gallas MR, Collnot E, Schaefer UF, Guterres SS, Lehr CM.

Eur J Pharm Biopharm. 2007 Aug;67(1):18-30. Epub 2007 Jan 25.

PMID:
17317124
19.

Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method.

Avdeef A, Artursson P, Neuhoff S, Lazorova L, Gråsjö J, Tavelin S.

Eur J Pharm Sci. 2005 Mar;24(4):333-49. Epub 2005 Jan 20.

PMID:
15734300
20.

Evaluating the effect of coating equipment on tablet film quality using terahertz pulsed imaging.

Haaser M, Naelapää K, Gordon KC, Pepper M, Rantanen J, Strachan CJ, Taday PF, Zeitler JA, Rades T.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1095-102. doi: 10.1016/j.ejpb.2013.03.019. Epub 2013 Apr 4.

PMID:
23563103
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk